Placebo 2 mg clinical trials

Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica

This study is looking at a new drug called baricitinib, alongside standard steroids, to treat Polymyalgia Rheumatica (PMR). We want to see if it helps reduce the need for steroids and keeps PMR under control, with fewer side effects than long-term steroid use.